Ranked by reported Q3 2025 13F market value
Share of total reported institutional value in DHAI held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | ORBIMED ADVISORS LLC | 1.9M | $358K | 0.0% | 113.290% | 0.01% |
| 2 | VANGUARD GROUP INC | 1.2M | $232K | -1.2% | 73.260% | 0.00% |
| 3 | CITADEL ADVISORS LLC | 254K | $48K | β | 15.049% | 0.00% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 244K | $46K | +3.9% | 14.422% | 0.00% |
| 5 | CITIGROUP INC | 50K | $9K | β | 2.987% | 0.00% |
| 6 | ACT Advisors, LLC. | 45K | $8K | +302.0% | 2.663% | 0.00% |
| 7 | XTX Topco Ltd | 25K | $5K | -79.0% | 1.491% | 0.00% |
| 8 | NORTHERN TRUST CORP | 24K | $4K | 0.0% | 1.404% | 0.00% |
| 9 | Tower Research Capital LLC (TRC) | 13K | $2K | -5.0% | 0.749% | 0.00% |
| 10 | STATE STREET CORP | 12K | $2K | 0.0% | 0.721% | 0.00% |
| 11 | GOLDMAN SACHS GROUP INC | 11K | $2K | β | 0.644% | 0.00% |
| 12 | Parallel Advisors, LLC | 4K | $691 | 0.0% | 0.219% | 0.00% |
| 13 | UBS Group AG | 3K | $621 | -89.6% | 0.197% | 0.00% |
| 14 | BlackRock, Inc. | 2K | $376 | 0.0% | 0.119% | 0.00% |
| 15 | BANK OF AMERICA CORP /DE/ | 202 | $38 | -31.5% | 0.012% | 0.00% |
| 16 | SBI Securities Co., Ltd. | 110 | $21 | -64.5% | 0.006% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in DHAI β a direct measure of their conviction.
Filings activity in DHAI during Q3 2025, grouped by how each filer changed its position.
7 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q3 2025 | 16 | 20% | 199.99% | +0.00 pp | $1M | 21% |
| Q2 2025 | 20 | +5.3% | 199.99% | +0.00 pp | $1M | 31% |
| Q1 2025 | 19 | +19% | 199.99% | +0.00 pp | $1M | 2.0% |
| Q4 2024 | 16 | +6.7% | 199.99% | +0.00 pp | $1M | 33% |
| Q3 2024 | 15 | +0.0% | 199.99% | +0.00 pp | $2M | 28% |
| Q2 2024 | 15 | +36% | 199.99% | +0.00 pp | $3M | +570% |
| Q1 2024 | 11 | β | 199.99% | β | $0M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying DHAI stock.
Based on Q3 2025 13F filings, institutional ownership of DIH Holding US, Inc. stands at 200.0%, held across 16 reporting institutions.
ORBIMED ADVISORS LLC is the largest reported institutional holder of DHAI, with approximately 1,915,000 shares worth $0.00B as of Q3 2025.
Yes β 1 widely-followed marquee investor appear among the top 25 institutional holders of DHAI, including CITADEL ADVISORS LLC.
Our composite Smart Money Score for DHAI is 39 out of 100 (Bearish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
3 institutions opened new positions in DHAI during Q3 2025, while 7 fully exited. 1 added to existing positions and 12 trimmed.
DHAI institutional ownership rose by 0.00 percentage points quarter-over-quarter, with a net change of -4 holders.
The top 10 institutions account for 99.5% of all reported 13F value in DHAI, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.